WHO plans clinical trials for Bundibugyo virus treatments in DRC and Uganda (nature.com)

• WHO plans trials of remdesivir and MBP134 for Bundibugyo virus in DRC and Uganda.
• Outbreak: 348 suspected cases, 89 deaths (as of 18 May 2026).
• MBP134 effective in monkey studies; remdesivir previously tested against other ebolaviruses.

"The WHO is preparing to trial two experimental treatments—remdesivir and MBP134—for Bundibugyo virus disease in the DRC and Uganda, where an outbreak has caused 348 suspected cases and 89 deaths. No approved treatments exist for this Ebola species. Animal studies show MBP134 is effective against Bundibugyo. The trials await government approval."